To print this article, all you need is to be registered or login on Mondaq.com.
On Monday, April 22, the Centers for Medicare & Medicaid
Services (CMS) released two highly anticipated final rules.
Together, these rules reshape the federal regulatory landscape for
Medicaid and the Children’s Health Insurance Program (CHIP),
particularly with respect to standards for ensuring access to care,
transparency, and oversight of provider payment rates, creating
opportunities for public input (especially for people enrolled in
Medicaid), quality measurement, and program accountability.
The first rule, which focuses on managed care delivery systems,
is titled “Managed Care Access, Finance, and
Quality” (or the “Managed Care Final Rule”).
The second final rule, which focuses on fee-for-service (FFS)
delivery systems and program improvements for home and
community-based services (HCBS) across delivery systems, is titled
“Ensuring Access to Medicaid Services”
(or the “Access Final Rule”). Although the two rules
largely focus on different delivery systems, they share common
goals and themes, with some provisions in each applying across
multiple delivery systems.
These final rules represent the most significant changes to
federal Medicaid and CHIP regulations since CMS established the
existing regulatory framework for managed care in 2016. These
changes are all the more noteworthy because of the magnitude of
these programs: together, Medicaid and CHIP provide health coverage
to more than 85 million people nationwide. Three out of four of
these individuals receive covered benefits through managed care
plans that contract with the state.
For the most part, CMS finalized the provisions described in its
May 2023 proposed rules with only minor revisions, clarifications,
and technical corrections. However, CMS departed from the proposed
rule in a few notable respects in response to the large volume of
public comments (415 on the Managed Care Proposed Rule and more
than 2,100 on the Access Proposed Rule).
The final rules officially take effect on July 9, 2024, but for
most provisions, CMS has defined implementation deadlines that vary
from 60 days to six years following this effective date.
This newsletter summarizes significant provisions and
overarching themes across both final rules. A more comprehensive
section-by-section analysis is available through Manatt on
Health (see details below). In addition, Manatt Health is
hosting a three-part public webinar series on these final rules. In
this series, Manatt Health’s multidisciplinary team will
unpack the newly finalized rules, offering key insights and
implications for stakeholders such as Medicaid enrollees,
providers, managed care organizations, and state
governments.
Key Provisions in the Final Rules
The Managed Care Final Rule includes
provisions that, among other things:
- Strengthen access to care and access monitoring requirements in
managed care programs by establishing federal minimum standards for
appointment wait times for certain services, enhancing state
requirements for access monitoring, and requiring states to publish
analyses of managed care plans’ aggregate provider payments
for certain services. Recognizing the rise of telehealth, CMS also
provides new clarity to states and managed care plans about how to
account for telehealth when monitoring for timely access and
network adequacy. - Codify and revise the federal regulations governing State
Directed Payments (SDPs)—through which states can establish
parameters for managed care plans’ provider payments—by
creating new flexibilities for certain types of SDPs while
codifying or strengthening the guardrails around
others. (Manatt will be releasing additional newsletters
unpacking these changes to SDPs and Medicaid financing). - Codify and build on recent CMS policy changes regarding
“in lieu of services” (ILOS), a mechanism through which
managed care plans can provide alternatives to standard covered
services when it is medically appropriate and cost-effective. - Modify Medical Loss Ratio (MLR) methodologies and processes to
align more closely with comparable MLR requirements for the
commercial health insurance market, increase accuracy of plan
reporting for rate-setting purposes, and allow for more consistent
comparisons across each plan’s different managed care
business lines and from state to state. - Establish a national framework and enhance requirements for
managed care quality rating systems (QRS) to increase
accountability for plans, assist beneficiaries with plan selection,
and make various other changes to the existing provisions governing
states’ managed care quality strategies and quality
monitoring. Out of all the provisions in the Managed Care Final
Rule, CMS expects that implementing these QRS requirements will
require the greatest investments in technology and staff time, for
both states and managed care plans.
The Access Final Rule includes
provisions that, among other things:
- Create new transparency and consultation requirements for FFS
provider payment rates, including a requirement for states to
publish analyses comparing the Medicaid FFS rates for certain
services against corresponding Medicare FFS rates, the
establishment of an “interested parties’ advisory
group” to advise and consult on payment rates for certain
HCBS, and significant new procedural requirements for certain types
of FFS rate changes. These provisions replace the current
requirements for triennial Access Monitoring Review Plans, which
are rescinded as of the rule’s effective date. - Modify the procedures for requesting federal approval to reduce
or restructure FFS rates, by requiring additional supporting
analyses with respect to state plan amendments (SPAs) that, based
on a preliminary review, present potential risks to
beneficiaries’ access to services. - Strengthen program advisory groups. States must create and
support a Medicaid Advisory Committee (MAC) comprising diverse
stakeholders, and a Beneficiary Advisory Council (BAC) comprising
solely of people with lived experience and reflecting the diverse
population in the Medicaid program. These two groups—which
replace the currently required Medical Care Advisory Committee
(MCAC)—will provide input to the state Medicaid agency on a
broad scope of program issues such as eligibility, coverage, access
to care, and quality of care. - Update HCBS program standards and processes regarding care
access, quality, and payment, including a requirement that at least
80% of Medicaid payments for certain home-based services go to
compensation for the individual direct care workers who provide
these services (a proposal that drew a large volume of comments
both for and against, and which was modified in several respects in
the final rule); new standards and reporting requirements related
to person-centered service plans, waiting lists, and other access
measures; a requirement to establish an HCBS grievance system and
incident management system in FFS (similar to what is already
required for HCBS delivered through managed care); and a new
regulatory framework to require state reporting of performance
measures from the HCBS Quality Measure Set (which has, to date,
been voluntary). CMS estimates that, for states, implementing the
updated critical incident system will be by far the costliest
component of these two final rules.
Key Themes Across the Two Final Rules
Several key themes emerge from the thousands of pages that make
up the proposed and final rules and their accompanying
preambles:
- These rules will significantly increase transparency for
Medicaid and CHIP program data related to provider payments and
access to care. States and managed care plans must soon begin
publishing several new types of data sets and reports, which must
be publicly available in a standardized format and with relevant
context. - The final rules show CMS’s continued emphasis on
addressing health disparities and advancing health equity.
Consistent with the U.S. Department of Health and Human
Services’ (HHS) overall focus on equity in its administration
of Medicaid and CHIP, Medicare, and the Marketplaces, these rules
evince an effort to identify and disclose health disparities (e.g.,
by requiring states to stratify data based on race and other
demographic factors), emphasize meaningful engagement of people
enrolled in Medicaid and CHIP (e.g., by supporting enrollee
participation in advisory groups, requiring enrollee experience
surveys, and requiring that program data be easy for the public to
find and understand). - CMS seeks to align standards and approaches across federally
regulated health care programs. Across multiple provisions, CMS
looks to existing standards for Medicare and the Marketplace to
inform and align Medicaid and CHIP with these standards. Examples
include the Medicaid/Medicare comparative payment analyses
mentioned above, as well as CMS’s efforts to align the
standards and quality measures for Medicaid and CHIP managed care
more closely with Qualified Health Plans sold on the
Marketplace. - The rules impose significant new requirements on states and
managed care plans, which CMS seeks to mitigate through regulatory
design, phased-in implementation, and technical assistance. CMS
estimates that states, plans, and providers will collectively spend
almost $500 million to implement these rules over the next 10
years. Many of CMS’s reforms require new or expanded analyses
and reporting by states and plans, upgraded IT infrastructure, and
additional state monitoring and oversight responsibilities. For
states already stretched thin as they unwind the COVID-19
continuous coverage requirement, these new requirements could pose
significant challenges, especially in light of CMS’s recently
finalized reforms for eligibility and enrollment systems. In
certain areas, CMS also attempts to mitigate administrative burdens
on states. - The final rules define new processes for enforcement and
dispute resolution between states and CMS. The final rules increase
not only the volume and types of data that will be available for
CMS oversight, but also the types of procedural mechanisms at
CMS’s disposal to bring states into compliance
The Managed Care Final Rule and Access Final Rule represent a
significant modernization of the framework for defining, measuring,
and enforcing the standards for access to care in Medicaid and
CHIP. States and managed care plans—and CMS itself—will
be hard at work in the coming years implementing these
requirements, including making policy decisions in areas where the
rules leave room for flexibility. Meanwhile, beneficiaries,
providers, and other stakeholders will be eagerly awaiting the new
reports required under the rule, while also encouraging their state
and local plans to implement the rule in a manner that promotes
adequate provider payments and beneficiary access to care.
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.
POPULAR ARTICLES ON: Food, Drugs, Healthcare, Life Sciences from United States
#CMS #Finalizes #Sweeping #Regulations #Medicaid #Access #Managed #Care #HCBS #Healthcare